Chief Accounting Officer
Inspired Entertainment, Inc. (INSE)Equibles does not estimate personal net worth.
Get an email with a short summary when Sarepta Therapeutics, Inc. publishes a filing, an earnings call transcript or a press release.
Get SRPT alertsJames Richardson is recorded as Chief Accounting Officer and CFO at Inspired Entertainment, Inc. (INSE) since January 1, 2025. Earlier roles on record: Board Member at VirTra, Inc (VTSI) until December 31, 2022. Inspired Entertainment, Inc. reported in an 8-K filed May 18, 2026 that James Richardson resigned as Executive Vice President and Chief Financial Officer. Inspired Entertainment, Inc. reported in an 8-K filed November 12, 2024 that James Richardson was appointed Chief Accounting Officer, effective January 1, 2025. Inspired Entertainment, Inc. reported in an 8-K filed November 12, 2024 that James Richardson was appointed Chief Financial Officer, effective January 1, 2025. Equibles holds 4 filed executive changes naming James Richardson; each is listed under recent activity with its source filing. The proxy statement of Inspired Entertainment, Inc. reports total compensation of $1,107,432 for James Richardson in fiscal 2025, including a base salary of $395,510. James Richardson has spoken on 2 earnings calls across 1 company, most recently for Sarepta Therapeutics, Inc. on November 5, 2026. Sarepta Therapeutics, Inc. is classified in the Biotechnology industry within the Healthcare sector. Inspired Entertainment, Inc. is classified in the Gambling industry within the Consumer Cyclical sector. Other leadership on record at Sarepta Therapeutics, Inc. includes Douglas Ingram (CEO and Board Member), Michael Severino, M.D. (CEO and Board Member), M. Kathleen Behrens (Chairman) and 7 others.
“On May 18, 2026, Inspired Entertainment, Inc. (the "Company") announced that James Richardson had stepped down from his role as Executive Vice President and Chief Financial Officer of the Company.”
“Mr. Richardson will also serve as the Company's Chief Accounting Officer.”
“Just to reiterate, I think we will get a large range of exposure out of these upcoming readouts, but as Mike has referenced in the FSHD program, there is a higher dose cohort that is still in the clinic at the moment that we'll get a read on early next year.”
“I had a question on SRP1001 and the dose response with respect to muscle concentration. When you doubled the dose, you got about a six-fold supralinear increase in muscle concentration.”
2025-01-01–present
2025-01-01–present
Source not stated
Start not stated–2026-05-18
Start not stated–2022-12-31
Biotechnology · Healthcare
Gambling · Consumer Cyclical
Chief Accounting Officer, CFO
2025-01-01–present
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2025 | Inspired Entertainment, Inc. (INSE) | Executive VP and CFO | $395,510 | $1,107,432 |
